Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1212084

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1212084

NGS-Based RNA-Sequencing

PUBLISHED:
PAGES: 196 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5450
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16350

Add to Cart

Description

Table of Contents

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global NGS-Based RNA-Sequencing Market to Reach $8.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for NGS-Based RNA-Sequencing estimated at US$2 Billion in the year 2022, is projected to reach a revised size of US$8.6 Billion by 2030, growing at a CAGR of 20.2% over the analysis period 2022-2030. Sequencing Platforms & Consumables, one of the segments analyzed in the report, is projected to record a 20.7% CAGR and reach US$4.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Sample Preparation segment is readjusted to a revised 17.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $579 Million, While China is Forecast to Grow at 18.9% CAGR

The NGS-Based RNA-Sequencing market in the U.S. is estimated at US$579 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 18.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.4% and 17.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.5% CAGR.

Select Competitors (Total 46 Featured):

  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • GATC Biotech AG
  • Illumina, Inc.
  • Macrogen, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.
Show more
Product Code: MCP13599

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • RNA-Seq: An Introduction
    • A Prelude to NGS-based RNA-seq Market
    • North America: The Largest Market for NGS-based RNA-seq
    • NGS-based RNA-seq - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • NGS-based RNA-seq Market Drivers and Restraints
    • Recent Advances in RNA Sequence Analysis
    • Select Players of NGS-based RNA-seq Market
    • Rise in Research Grants to Improve Activities in NGS-based RNA-Sequencing Technique
    • Application of RNA-Seq in Precision Medicine
    • Next Generation Sequencing in Cancer Research
    • Next Generation Sequencing for Transcriptomic Profiling
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Sequencing by Synthesis (SBS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Sequencing by Synthesis (SBS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Ion Semiconductor Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Ion Semiconductor Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Single-molecule Real-time (SMRT) Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Single-molecule Real-time (SMRT) Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World NGS-Based RNA-Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 15: World 8-Year Perspective for NGS-Based RNA-Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Sequencing Platforms & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World 8-Year Perspective for Sequencing Platforms & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 19: World 8-Year Perspective for Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Sequencing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 21: World 8-Year Perspective for Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Data Analysis, Storage & Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World 8-Year Perspective for Data Analysis, Storage & Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Research Centers & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 25: World 8-Year Perspective for Research Centers & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 27: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: USA 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: USA 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
  • CANADA
    • TABLE 34: Canada Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Canada 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Canada 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
  • JAPAN
    • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 40: Japan Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Japan 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Japan 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
  • CHINA
    • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 46: China Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 47: China 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: China 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
  • EUROPE
    • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 52: Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Europe 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Europe 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe 8-Year Perspective for NGS-Based RNA-Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 59: Europe 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
  • FRANCE
    • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 60: France Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: France 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 64: France Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: France 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
  • GERMANY
    • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 66: Germany Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Germany 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 70: Germany Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Germany 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
  • ITALY
    • TABLE 72: Italy Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 73: Italy 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 76: Italy Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 77: Italy 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
  • UNITED KINGDOM
    • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 78: UK Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 79: UK 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 82: UK Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 83: UK 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
  • ASIA-PACIFIC
    • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Rest of World 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of World 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
    • TABLE 100: Rest of World Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 101: Rest of World 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!